Select Publications
Patents
2007, Compounds for treating Cancer, Australia, Patent No. Australian Provisional Patent Application No 2007906570
,2005, Identification of compounds for the treatment of proliferative disorders, Australia, Patent No. Australian Provisional Patent Application No 2004906888
,Preprints
2024, A truncation mutant of adenomatous polyposis coli (APC) impairs apical cell extrusion through elevated epithelial tissue tension, , http://dx.doi.org/10.1101/2024.03.06.583801
,2023, Spatial and Temporal Coordination of Force-generating Actin-based Modules Drives Membrane Remodeling In Vivo., , http://dx.doi.org/10.1101/2023.12.04.569944
,2023, Pre-existing tissue mechanical hypertension at adherens junctions disrupts apoptotic extrusion in epithelia, , http://dx.doi.org/10.1101/2023.08.31.555652
,2023, Specialized actin nanoscale layers control focal adhesion turnover, , http://dx.doi.org/10.1101/2023.02.15.528622
,2022, Highly efficient platelet generation in lung vasculature reproduced by microfluidics, , http://dx.doi.org/10.21203/rs.3.rs-2306404/v1
,2022, Precision super-resolution cryo-correlative light and electron microscopy for rapidin situstructural analyses of optogenetically-positioned organelles, , http://dx.doi.org/10.1101/2022.11.22.516823
,2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer, , http://dx.doi.org/10.1101/2022.09.29.510034
,2021, Platelet generation from circulating megakaryocytes is triggered in the lung vasculature, , http://dx.doi.org/10.1101/2021.11.01.466743
,2021, Platelet generation from circulating megakaryocytes is triggered in the lung vasculature, , http://dx.doi.org/10.21203/rs.3.rs-690639/v1
,2019, Tropomyosin Tpm3.1 is required to maintain the structure and function of the axon initial segment, , http://dx.doi.org/10.1101/711614
,Precision Super-Resolution Cryo-Correlative Light and Electron Microscopy for Rapid <i>in situ</i> Structural Analyses of Optogenetically-Positioned Organelles, , http://dx.doi.org/10.2139/ssrn.4309027
,Tropomyosin Tpm3.1 is Required to Maintain the Structure and Function of the Axon Initial Segment, , http://dx.doi.org/10.2139/ssrn.3448139
,